Allosteric ribozyme-driven crRNA switch for the amplification-free detection of biomolecules
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Mei Su und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of…. Hauptthemen laut MEDLINE: Biosensing Techniques, RNA, Catalytic, MicroRNAs, Adenosine Triphosphate. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
Currently, CRISPR-mediated biosensors are concentrating on the design of the crRNA or the activator strand to regulate the trans-cleavage activity of Cas12a. Herein, we report an allosteric ribozyme-driven crRNA switch-regulated CRISPR/Cas12a sensor for amplification-free detection of biomolecules. An allosteric ribozyme is meticulously engineered to connect the target recognition sequence with the 5' binding arm of the hammerhead ribozyme, resulting in the formation of a hairpin structure through complementary hybridization. The presence of target induces the conformational change in the allosteric module and disrupts the hairpin structure, restoring multiple-turnover cleavage RNA activity of ribozyme. Then, the activated ribozyme specifically cuts the cleavage site of the substrate-locked crRNA and releases the native crRNA to initiate CRISPR/Cas12a functions for signal reporting. The reported biosensor exhibited high sensitivity and excellent specificity for miR-155 and adenosine triphosphate (ATP) detection, giving the detection limits of 256 fM and 160 nM, respectively. For clinical validation, our proposed strategy can quantify miR-155 expression levels in cells and serum of cancer patients. Furthermore, we also demonstrate that the allosteric ribozyme-driven crRNA switch can be easily compatible with lateral flow assays, realizing visualization and the portable monitoring of target. Hence, the biosensor not only has outstanding potential in point-of-care testing, but also enables the detection of various biomolecules by flexibly substituting target recognition sequences for molecular diagnosis in the clinic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Green Organic Synthesis and Application of Hunan Province, Key Laboratory of Environmentally Friendly Chemistry and Application of Ministry of Education, College of Chemistry, Xiangtan University, Xia…
- Hunan Provincial Clinical Research Center for Metabolic Associated Fatty Liver Disease, Clinical Research Institute, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, 421002,…
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Su, M., Zhang, H. S., Liu, H., Yang, K., & Ying, Z. M. (2025). Allosteric ribozyme-driven crRNA switch for the amplification-free detection of biomolecules. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117450
Vancouver
Su M, Zhang HS, Liu H, Yang K, Ying ZM. Allosteric ribozyme-driven crRNA switch for the amplification-free detection of biomolecules. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117450
BibTeX
@article{Su2025,
author = {Su, Mei and Zhang, Hong-Shuai and Liu, Hao and Yang, Kai and Ying, Zhan-Ming},
title = {Allosteric ribozyme-driven crRNA switch for the amplification-free detection of biomolecules},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117450}
}
EUVIMED